An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...

Independence Blue Cross said starting Jan. 1 it will only be covering GLP-1 agonists — commonly sold under brand names like ...

Ozempic is a drug for diabetes, but it's also being used off-label for weight loss. Its active ingredient has inspired a new ...

The Maryland program’s spending on both obesity drugs grew 86% year-over-year, Real Chemistry said, the seventh highest in ...

Pennsylvania's Medicaid spending per enrollee on Wegovy, Zepbound, and other anti-obesity drugs was third-highest in the ...

Results for its new CagriSema drug, while promising, fell below expectations, sending shares of the pharmaceutical giant down ...

Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...

The effects that a pause may have on your body may depend on why you're taking the medication in the first place.

A new study put Eli Lilly's Zepbound and Novo Nordisk's Wegovy to the test. Here's which one will help you lose more weight.

Britons paying privately for obesity drugs are increasingly choosing Eli Lilly's Mounjaro over Novo Nordisk's Wegovy, online ...

With so many weight loss medications on the market, it’s easy to feel overwhelmed by the options. From brand-name heavy ...